Your English writing platform
Discover LudwigSuggestions(5)
Exact(12)
The involvement of DDAH function in the regulation of NOS makes this enzyme a potentially attractive therapeutic target.
Differences at the active site loop of the host and parasite LDH's makes this enzyme an attractive target for drug inhibitors.
The role of 17β-HSD3 in testosterone biosynthesis makes this enzyme an attractive molecular target for small molecule inhibitors for the treatment of prostate cancer.
Simultaneous enhanced organic solvent and thermal stability makes this enzyme an ideal candidate for glycoconjugate synthesis in aqueous-organic solvent systems.
The production at low temperature (30 °C) indicates the mesophilic nature of A. niger KIBGE-IB36 and the production of endo-1,4-β xylanase at alkaline pH makes this enzyme a promising candidate for bio-bleaching processes and other industrial applications.
In spite of the crucial role played by IN in the retroviral life cycle, which makes this enzyme an attractive target for the development of new anti-AIDS agents, very few inhibitors have been described and none seems to have a potential use in anti-HIV therapy.
Similar(48)
We discovered that my son inherited two different (thus-far-unique) mutations in the same gene — the NGLY1 gene — which encodes the enzyme N-glycanase 1. Consequently, he cannot make this enzyme.
This characteristics made this enzyme suitable for structure function studies.
These features, in combination with the biocatalytic properties of BVMOAf1, make this enzyme a promising biocatalyst.
In particular, its wide substrate scope and high stability make this enzyme a potential candidate for various Baeyer-Villiger oxidations.
It retained 44% of its maximum activity at 10°C, making this enzyme more attractive for municipal wastewater treatment 10-25°C 10-25°C
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com